Cardlytics Inc has a consensus price target of $10.86, established from looking at the 31 latest analyst ratings. The last 3 analyst ratings were released from Needham, Lake Street, and Craig-Hallum on April 9, 2024, March 15, 2024, and March 15, 2024. With an average price target of $17.67 between Needham, Lake Street, and Craig-Hallum, there's an implied 47.96% upside for Cardlytics Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
04/09/2024 | CDLX | Buy Now | Cardlytics | $11.94 | 42.38% | Needham | Kyle Peterson | $15 → $17 | Maintains | Buy | Get Alert |
03/15/2024 | CDLX | Buy Now | Cardlytics | $11.94 | 50.75% | Lake Street | Jacob Stephan | $13 → $18 | Maintains | Buy | Get Alert |
03/15/2024 | CDLX | Buy Now | Cardlytics | $11.94 | 50.75% | Craig-Hallum | Jason Kreyer | $10 → $18 | Upgrade | Hold → Buy | Get Alert |
03/15/2024 | CDLX | Buy Now | Cardlytics | $11.94 | 25.63% | Needham | Kyle Peterson | $12 → $15 | Maintains | Buy | Get Alert |
01/30/2024 | CDLX | Buy Now | Cardlytics | $11.94 | 0.5% | Needham | Kyle Peterson | → $12 | Reiterates | Buy → Buy | Get Alert |
11/29/2023 | CDLX | Buy Now | Cardlytics | $11.94 | 8.88% | Lake Street | Jacob Stephan | → $13 | Initiates | → Buy | Get Alert |
11/09/2023 | CDLX | Buy Now | Cardlytics | $11.94 | 0.5% | Needham | Kyle Peterson | $19 → $12 | Maintains | Buy | Get Alert |
08/02/2023 | CDLX | Buy Now | Cardlytics | $11.94 | -24.62% | JP Morgan | Doug Anmuth | $6 → $9 | Maintains | Neutral | Get Alert |
08/02/2023 | CDLX | Buy Now | Cardlytics | $11.94 | 59.13% | Needham | Kyle Peterson | $10 → $19 | Maintains | Buy | Get Alert |
06/06/2023 | CDLX | Buy Now | Cardlytics | $11.94 | -16.25% | Needham | Kyle Peterson | → $10 | Reiterates | Buy → Buy | Get Alert |
05/05/2023 | CDLX | Buy Now | Cardlytics | $11.94 | -16.25% | Needham | Kyle Peterson | $8 → $10 | Maintains | Buy | Get Alert |
04/12/2023 | CDLX | Buy Now | Cardlytics | $11.94 | -49.75% | Wells Fargo | Jeff Cantwell | $5 → $6 | Maintains | Underweight | Get Alert |
04/05/2023 | CDLX | Buy Now | Cardlytics | $11.94 | -33% | Needham | Mayank Tandon | → $8 | Reiterates | → Buy | Get Alert |
03/02/2023 | CDLX | Buy Now | Cardlytics | $11.94 | -49.75% | JP Morgan | Doug Anmuth | $7 → $6 | Maintains | Neutral | Get Alert |
03/02/2023 | CDLX | Buy Now | Cardlytics | $11.94 | -58.12% | Wells Fargo | Jeff Cantwell | $6 → $5 | Maintains | Underweight | Get Alert |
03/02/2023 | CDLX | Buy Now | Cardlytics | $11.94 | -33% | Needham | Kyle Peterson | $14 → $8 | Maintains | Buy | Get Alert |
01/09/2023 | CDLX | Buy Now | Cardlytics | $11.94 | -49.75% | Wells Fargo | Jeff Cantwell | $10 → $6 | Maintains | Underweight | Get Alert |
11/02/2022 | CDLX | Buy Now | Cardlytics | $11.94 | -16.25% | Wells Fargo | Jeff Cantwell | $13 → $10 | Maintains | Underweight | Get Alert |
11/02/2022 | CDLX | Buy Now | Cardlytics | $11.94 | 17.25% | Needham | Kyle Peterson | $19 → $14 | Maintains | Buy | Get Alert |
The latest price target for Cardlytics (NASDAQ: CDLX) was reported by Needham on April 9, 2024. The analyst firm set a price target for $17.00 expecting CDLX to rise to within 12 months (a possible 42.38% upside). 11 analyst firms have reported ratings in the last year.
The latest analyst rating for Cardlytics (NASDAQ: CDLX) was provided by Needham, and Cardlytics maintained their buy rating.
The last upgrade for Cardlytics Inc happened on March 15, 2024 when Craig-Hallum raised their price target to $18. Craig-Hallum previously had a hold for Cardlytics Inc.
The last downgrade for Cardlytics Inc happened on September 8, 2022 when Wells Fargo changed their price target from $14 to $13 for Cardlytics Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cardlytics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cardlytics was filed on April 9, 2024 so you should expect the next rating to be made available sometime around April 9, 2025.
While ratings are subjective and will change, the latest Cardlytics (CDLX) rating was a maintained with a price target of $15.00 to $17.00. The current price Cardlytics (CDLX) is trading at is $11.94, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.